Sernova Biotherapeutics Announces Promising Interim Results in Type 1 Diabetes Trial, Offering Hope for Functional Cure
Sernova Biotherapeutics Inc has announced positive interim data from its Phase 1/2 clinical trial of the Cell Pouch Bio-hybrid Organ, bringing hope for a functional cure for Type 1 Diabetes.
3 minutes to read